Evidence map›Paper›PMID 26017739›Full record

ReviewEuropean radiology2016

Estimating GFR prior to contrast medium examinations--what the radiologist needs to know!

Ulf Nyman, Jonas Björk, Sten-Erik Bäck, Gunnar Sterner, Anders Grubb

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in European radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ulf NymanDepartment of Translational Medicine, Division of Medical Radiology, Skåne University Hospital, Malmö, Sweden. ulf.nyman@bredband.net.
Jonas BjörkR&D Centre Skåne, Skåne University Hospital, Lund, Sweden.
Sten-Erik BäckDepartment of Clinical Chemistry, Skåne University Hospital, Lund, Sweden.
Gunnar SternerDepartment of Nephrology, Skåne University Hospital, Malmö, Sweden.
Anders GrubbDepartment of Clinical Chemistry, Skåne University Hospital, Lund, Sweden.
Skåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledCreatinine-based equations to estimate glomerular filtration rate (GFR) are increasingly used in radiological practice and in studies on contrast medium-induced acute kidney injury (CIAKI). Their use is recommended in guidelines and contrast medium textbooks to identify patients at risk of CIAKI or nephrogenic systemic fibrosis. There is also an increased interest in cystatin C-based equations. Adopting GFR equations requires local creatinine and cystatin C assay calibrations to equal those used in developing the equations to avoid overestimation or underestimation of renal function. Methods should preferably be traceable to international standards, and assay traceability should be defined in CIAKI studies. Absolute GFR (mL/min) should be used when dosing contrast media and relating the dose to CIAKI instead of commonly used relative GFR (mL/min/1.73 m(2)) estimates. Accuracy of creatinine and cystatin C equations (percentage of GFR estimates within 30% of measured GFR) ranges between 75% and 85%. Equations combining creatinine and cystatin C may reach 90%, an accuracy similar to clearance methods (used as a reference test when developing and validating equations) when compared to the gold standard, renal clearance of inulin. The local laboratory or nephrology experts should be consulted in matters of method calibration and choice of GFR equation. KEY POINTS: • Traceability of creatinine/cystatin C assays used in GFR equations must be defined. • Absolute, not relative, GFR should be used when dosing contrast media. • Consult the local laboratory or nephrologist to choose the proper GFR equation.

Indexed as

Acute Kidney InjuryContrast MediaCreatinineCystatin CGlomerular Filtration RateHumansKidneyKidney Function TestsContrast MediaCreatinineCystatin CContrast materialsCreatinineGlomerular filtration rateKidney diseaseKidney insufficiency

Identifiers

PMID26017739
OpenAlexW1539692200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.